ENGSVSPACB• 28 Days (Normalized)
ENGS vs PACB (Energys Group Limited vs Pacific Biosciences of California Inc.)
Showing Closing Date Range from Sep 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ENGS Performance $3.16
+9.34%
Energys Group Limited
Normalized Baseline0.00%
PACB Performance $2.72
+110.85%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
-101.51 pts
PACB outperforming by 101.51 percentage points
ENGSPACB
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ENGS PACB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | ENGS Price | ENGS Gain (%) | PACB Price | PACB Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $3.16 | +9.34% | $2.72 | +110.85% | -101.51% |
| Oct 06, 2026 | $3.12 | +7.96% | $2.70 | +109.30% | -101.34% |
| Oct 05, 2026 | $3.07 | +6.23% | $2.87 | +122.48% | -116.25% |
| Oct 02, 2026 | $3.05 | +5.54% | $2.54 | +96.90% | -91.36% |
| Oct 01, 2026 | $- | $2.51 | +94.57% | - | |
| Sep 30, 2026 | $- | $2.37 | +83.72% | - | |
| Sep 29, 2026 | $2.99 | +3.46% | $1.83 | +41.86% | -38.40% |
| Sep 28, 2026 | $2.96 | +2.42% | $1.71 | +32.56% | -30.14% |
| Sep 25, 2026 | $2.94 | +1.73% | $- | - | |
| Sep 24, 2026 | $2.91 | +0.69% | $1.46 | +12.79% | -12.10% |
| Sep 23, 2026 | $2.86 | -1.04% | $1.41 | +9.30% | -10.34% |
| Sep 22, 2026 | $2.85 | -1.38% | $- | - | |
| Sep 21, 2026 | $2.83 | -2.08% | $1.36 | +5.43% | -7.51% |
| Sep 18, 2026 | $2.82 | -2.42% | $1.37 | +6.20% | -8.62% |
| Sep 17, 2026 | $2.67 | -7.61% | $1.38 | +6.98% | -14.59% |
Page 1 of 2